Generics
We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements of EDQM (CEP), ICH (EuDMF, CTD), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.
Monohydrate
Therapeutic Area
Nervous system
Status
Commercial
EU DMF readiness
US DMF readiness
CAS No.
851220-85-4
Reference Product
Available also in injectable form